NDC 52427-803

Gralise

Gabapentin

Gralise is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Almatica Pharma Llc. The primary component is Gabapentin.

• Product ID: 52427-803_cccddde4-ca61-3a25-fbba-c97fdcfd5f9e
• NDC: 52427-803
• Product Type: Human Prescription Drug
• Proprietary Name: Gralise
• Generic Name: Gabapentin
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2020-10-01
• Marketing Category: NDA / NDA
• Application Number: NDA022544
• Labeler Name: Almatica Pharma LLC
• Substance Name: GABAPENTIN
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 52427-803-90

90 TABLET, FILM COATED in 1 BOTTLE (52427-803-90)

• Marketing Start Date: 2020-10-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Gralise" or generic name "Gabapentin"

NDC	Brand Name	Generic Name
13913-004	Gralise	Gralise
13913-005	Gralise	Gralise
50436-1262	Gralise	Gralise
52427-803	Gralise	Gralise
52427-806	Gralise	Gralise
52427-815	Gralise	Gralise
0093-4443	Gabapentin	Gabapentin
0093-4444	Gabapentin	Gabapentin
0143-3991	Gabapentin	Gabapentin
0143-3993	Gabapentin	Gabapentin
0143-3994	Gabapentin	Gabapentin
0143-9992	Gabapentin	Gabapentin
0143-9993	Gabapentin	Gabapentin
0143-9994	Gabapentin	Gabapentin
0071-0401	Neurontin	gabapentin
0071-0513	Neurontin	gabapentin
0071-0803	Neurontin	gabapentin
0071-0805	Neurontin	gabapentin
0071-0806	Neurontin	gabapentin
0071-2012	Neurontin	gabapentin